INVO Fertility (IVF) Current Deferred Revenue (2018 - 2025)
INVO Fertility (IVF) reported Current Deferred Revenue of $720407.0 for Q3 2025, up 28.09% year-over-year from $562402.0 in Q3 2024, and down 13.71% sequentially from $834850.0 in Q2 2025.
INVO Fertility (IVF) Current Deferred Revenue (2018 - 2025) Analysis & Trends
INVO Fertility has disclosed Current Deferred Revenue across 8 years of filings, most recently posting $720407.0 for Q3 2025.
- Quarterly Current Deferred Revenue rose 28.09% year-over-year to $720407.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $720407.0 (up 28.09% YoY) and the FY2024 annual result came in at $602359.0, up 47.36% from the prior year.
- Current Deferred Revenue declined to $720407.0 in Q3 2025, from $834850.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $3.4 million in Q1 2021 and bottomed at $5793.0 in Q1 2022.
- The 5-year median for Current Deferred Revenue is $416745.0 (2024), against an average of $544797.6.
- The widest YoY moves for Current Deferred Revenue: up 1931.8% in 2022, down 99.83% in 2022.
- INVO Fertility's Current Deferred Revenue stood at $5900.0 in 2021, then jumped by 1931.8% to $119876.0 in 2022, then surged by 240.99% to $408769.0 in 2023, then surged by 47.36% to $602359.0 in 2024, then gained by 19.6% to $720407.0 in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $720407.0, $834850.0, and $725330.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.31 Mn | 4.91 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 720,407.00 |
| Jun 30, 2025 | 834,850.00 |
| Mar 31, 2025 | 725,330.00 |
| Dec 31, 2024 | 602,359.00 |
| Sep 30, 2024 | 562,402.00 |
| Jun 30, 2024 | 416,745.00 |
| Mar 31, 2024 | 513,425.00 |
| Dec 31, 2023 | 408,769.00 |
| Sep 30, 2023 | 229,921.00 |
| Jun 30, 2023 | 161,187.00 |
| Mar 31, 2023 | 46,746.00 |
| Dec 31, 2022 | 119,876.00 |
| Sep 30, 2022 | 98,659.00 |
| Jun 30, 2022 | 77,357.00 |
| Mar 31, 2022 | 5,793.00 |
| Dec 31, 2021 | 5,900.00 |
| Sep 30, 2021 | 714,286.00 |
| Jun 30, 2021 | 714,286.00 |
| Mar 31, 2021 | 3.39 Mn |
| Dec 31, 2020 | 714,286.00 |